Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn's disease: Results from the phase 3 VIVID 1 study

JOURNAL OF CROHNS & COLITIS(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要